Dose-dense chemo aids high-risk breast cancer patients

MADRID – A dose-dense, third-generation chemotherapy regimen surpassed a more standard regimen for adjuvant therapy of high-risk breast cancer patients with positive nodes and either triple-negative...

Field of Interest: Oncology
Type: News Item

Rolapitant curbs chemo-induced nausea and vomiting

MADRID – The investigational neurokinin-1 receptor antagonist rolapitant met all of its endpoints in the prevention of chemotherapy-induced nausea and vomiting in a phase III trial. Among 532...

Field of Interest: Oncology
Type: News Item

New drug boosts survival in metastatic CRC

MADRID – Treatment with a new nucleoside-analogue drug produced clinically meaningful improvements in survival and performance status in a phase III trial that enrolled 800 patients with metastatic...

Field of Interest: Oncology
Type: News Item

New drug boosts survival in metastatic CRC

MADRID – Treatment with a new nucleoside-analogue drug produced clinically meaningful improvements in survival and performance status in a phase III trial that enrolled 800 patients with metastatic...

Field of Interest: Gastroentero...
Type: News Item

More people die from thin melanomas than thick melanomas

EDINBURGH – Contrary to the perception that most melanoma deaths result from thick melanomas, long-term data from Australia show that more people die who initially present with thin melanomas. Among...

Field of Interest: Dermatology
Type: News Item

MicroRNA test improved preop pancreatic cancer diagnosis

Cytology and a microRNA-based test identified pancreatic cancer 91% of the time in specimens obtained by endoscopic ultrasound-guided fine-needle aspiration – a substantial improvement, compared with...

Field of Interest: Oncology
Type: News Item

Veterans at increased risk of skin cancer

EDINBURGH – U.S. military personnel deployed overseas during the past decade have increased risk factors for skin cancer, a new survey suggests. Researchers reported that 77% of veterans were...

Field of Interest: Oncology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness